Novel Activating Antibodies for Viral Treatment
Novel Activating Antibodies for Viral Treatment Project ID : 47-2020-10898
Innovative Products and Technologies
Novel Activating Antibodies for Viral Treatment
Project ID : 47-2020-10898
Various pathogens (bacteria and viruses as well) bind to specific cell adhesion molecule in order to inhibit the immune response and/or to infect the host cells. However,upon binding and induction/activation, the cell adhesion molecule suppresses virus production by an SHP2-dependent process which involves also suppression of mTOR-mediated protein biosynthesis.
We propose our anti- cell adhesion molecule activating mAb as a broad antiviral therapy (including Covid-19) that will:
Project manager
Keren-Or Amar
VP, Business Development, Healthcare
Project researchers
Francesca Levi-Schaffer
HUJI, School of Medicine - IMRIC
School of Pharmacy- Institute for Drug Research
Yissum - Research Development Company of the Hebrew University
Technology Transfer Office from Israel
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.
Create your free account to connect with Yissum - Research Development Company of the Hebrew University and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Yissum - Research Development Company of the Hebrew University
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support